- Details
- Description
Strength:
80 mg
Composition:
Cabozantinib INN 80 mg
Treatment:
Oncology
Form:
Tablet
Brand:
Caboxen
Quantity Unit:
Tablets
Caboxen 80 (Cabozantinib INN 80 mg) is an oncology medicine manufactured by Everest Pharmaceuticals Ltd. It contains Cabozantinib INN 80 mg, an oral targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. Cabozantinib works by blocking specific signaling pathways involved in cancer-cell growth, tumor progression, and the formation of new blood vessels. It is used for the treatment of certain cancers according to the approved indication and medical supervision. Everest Pharmaceuticals officially lists Caboxen 80 in its oncology product portfolio.
